At Echometrix, our patented, breakthrough, ultrasound-based products
will be used to provide an objective, quantitative initial diagnosis
and to objectively measure patient outcomes during rehabilitation.
These advancements can potentially help decrease missed work days for
injured workers, improve athlete performance and measure the efficacy
of new therapies.
More than 1 in 4 Americans has a musculoskeletal condition requiring
medical attention. Approximately 28% of these conditions were the
result of musculoskeletal injuries. Out of a total of more than 24
million total injuries annually, 18.4 million sprain and strain
injuries are recorded. Our products will provide ongoing measurement
of tissue rehabilitation, optimizing physical therapy for workers,
soldiers and athletes.
Sprain and strain injuries cost U.S. healthcare payers $92 billion
annually. Use of MRI for the routine diagnosis of musculoskeletal
conditions will create a $2.5 billion cost problem in the U.S. by
2020, which could be avoided by increasing the use of ultrasound.
Echometrix's advanced ultrasound will help to significantly decrease
medical imaging costs.